Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic Shock

NCT03683329 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.

NCT NCT03683329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03683329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic Shock
Lead sponsor
Institut Paoli-Calmettes
Phase
Phase 3
Overall status
Completed
Start date
November 26, 2018
Completion date
July 26, 2024
Enrollment
398 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, critical care